関連する実験動画
Updated: Feb 24, 2026

07:38
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
Published on: May 27, 2021
8.8K
修正:ブプロピオンXLに関連する新規発症チック障害:まれな症例
Ovais Rashid1,2,3, Priyanka Hooda1, Simranjeet Kaur1
1Centre of Excellence in Mental Health, Psychiatry, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. RML Hospital, New Delhi, IND.
Cureus
|February 23, 2026
まとめ
この研究は、以前に公開された記事を訂正し、将来の研究の取り組みのために正確な科学的記録と信頼できるデータが確保されるようにします。
科学分野:
- 科学文献の訂正
- 学術コミュニケーションの整合性
背景:
- 公開された研究の正確性を確保することは、科学の進歩にとって重要です。
- 科学記録の完全性を維持することは、学術出版の基本的な側面です。
研究 の 目的:
- 特定の記事のデジタルオブジェクト識別子(DOI)の訂正を提供すること。
- 修正された科学作品の適切な引用と検索を保証すること。
主な方法:
- 間違ったDOIの特定。
- デジタルオブジェクト識別子(DOI)を修正するための訂正通知の発行。
主要な成果:
- 記事のデジタルオブジェクト識別子(DOI)10.7759/cureus.102855が修正されました。
- 科学出版物の正確なリンクとアクセシビリティが確保されました。
結論:
- 正確なDOIは、科学研究の発見可能性と引用にとって不可欠です。
- この訂正は、科学出版の基準を維持し、信頼できる知識の普及を促進します。
さらに関連する動画
関連する概念動画
Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Bipolar Disorder
1.1K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.1K
Mania and Antimanic Drugs: Overview
702
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
702
Oral Drug Delivery Systems: Continuous-Release Systems
58
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
58
Bulimia Nervosa
852
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
852
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.8K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.8K

